Greece Commits $1.2B to Lockheed F-16 Upgrades and F-35 Orders, Bolstering Backlog But Leaving Core Thesis Unchanged

What happened

Greece has announced plans to spend $1.2 billion upgrading older Lockheed Martin F-16 fighters and has orders for 20 to 40 F-35 stealth jets, adding to the company's international backlog. This move comes as Lockheed's total backlog stood at $193.6 billion at FY2025-end, with management guiding that 37% converts to revenue in the next 12 months. However, the stock's elevated valuation at 30.9x P-E prices in a near-term missile-defense step-up, particularly for PAC-3 MSE and THAAD interceptors, which remain dependent on funded contract conversions. The Greece deal, while positive, does not address these key risks or the political scrutiny over dividends and buybacks highlighted in recent SEC filings. Thus, this news reinforces steady demand but fails to provide the funded milestones needed to justify upside from current levels.

Implication

The $1.2 billion commitment from Greece will incrementally boost Lockheed's funded backlog and revenue over the coming years, supporting near-term visibility. Yet, this amount is relatively small, representing less than 1% of the total backlog, and thus has limited impact on earnings given the high valuation multiples. The investment case remains centered on the conversion of PAC-3 and THAAD frameworks into definitive, funded contracts, which are still subject to appropriations and lack interim milestones. Additionally, executive orders could constrain dividends and buybacks, a risk that persists despite this new demand and could break the shareholder-yield pillar. Therefore, investors should view this news as confirmation of ongoing business strength but not as a catalyst to change the WAIT rating or attractive entry points.

Thesis delta

This news does not materially shift the investment thesis. It confirms international demand for Lockheed's products but does not progress the critical missile-defense contract conversions or mitigate political risks to capital returns. The thesis remains unchanged, emphasizing the need to wait for funded awards and stability in shareholder yield policies.